1. Home
  2. AVDL vs CTOS Comparison

AVDL vs CTOS Comparison

Compare AVDL & CTOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • CTOS
  • Stock Information
  • Founded
  • AVDL 2015
  • CTOS 1988
  • Country
  • AVDL Ireland
  • CTOS United States
  • Employees
  • AVDL N/A
  • CTOS N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • CTOS Diversified Commercial Services
  • Sector
  • AVDL Health Care
  • CTOS Consumer Discretionary
  • Exchange
  • AVDL Nasdaq
  • CTOS Nasdaq
  • Market Cap
  • AVDL 1.4B
  • CTOS 1.3B
  • IPO Year
  • AVDL 1996
  • CTOS N/A
  • Fundamental
  • Price
  • AVDL $14.54
  • CTOS $6.14
  • Analyst Decision
  • AVDL Strong Buy
  • CTOS Buy
  • Analyst Count
  • AVDL 7
  • CTOS 3
  • Target Price
  • AVDL $19.86
  • CTOS $6.83
  • AVG Volume (30 Days)
  • AVDL 1.4M
  • CTOS 597.4K
  • Earning Date
  • AVDL 08-07-2025
  • CTOS 10-29-2025
  • Dividend Yield
  • AVDL N/A
  • CTOS N/A
  • EPS Growth
  • AVDL N/A
  • CTOS N/A
  • EPS
  • AVDL N/A
  • CTOS N/A
  • Revenue
  • AVDL $221,075,000.00
  • CTOS $1,901,675,000.00
  • Revenue This Year
  • AVDL $63.77
  • CTOS $13.58
  • Revenue Next Year
  • AVDL $29.91
  • CTOS $5.18
  • P/E Ratio
  • AVDL N/A
  • CTOS N/A
  • Revenue Growth
  • AVDL 132.35
  • CTOS 6.21
  • 52 Week Low
  • AVDL $6.38
  • CTOS $3.03
  • 52 Week High
  • AVDL $16.66
  • CTOS $6.64
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 70.53
  • CTOS 58.86
  • Support Level
  • AVDL $14.52
  • CTOS $5.91
  • Resistance Level
  • AVDL $14.99
  • CTOS $6.13
  • Average True Range (ATR)
  • AVDL 0.53
  • CTOS 0.24
  • MACD
  • AVDL -0.00
  • CTOS -0.00
  • Stochastic Oscillator
  • AVDL 63.55
  • CTOS 86.43

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About CTOS Custom Truck One Source Inc.

Custom Truck One Source Inc is a one-stop-shop provider of specialty equipment in the electric utility transmission and distribution, forestry, telecom, waste management, rail, and infrastructure end-markets in North America. The company's segment includes Equipment Rental Solutions (ERS), Truck and Equipment Sales (TES), and Aftermarket Parts and Services (APS). It generates maximum revenue from the TES segment. Geographically, it derives a majority revenue from the United States.

Share on Social Networks: